The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of patients with type 2 diabetes mellitus

Abstract

*background:Diabetes is a well-established independent risk factor for cardiovascular diseases (CVD). Compared with non-diabetic individuals, diabetic patients have 2 to 4 times increased risk for stroke and death from heart disease. *aim:-Studying the relationship between cardiometabolic index and severity of diabetes. *patients&methods: Cross sectional stydy, was carried out in the Clinical Pathology Department, Faculty of medicine, Sohag university hospital, on 200 patients known to have type 2 diabetes mellitus the outpatient diabetic clinic, in addition to 100 healthy individuals with the mean age as it was 53 years in all groups. *results: In our study group 2 (diabetic obese) showed the worst values for both lipid profile and HbA1c, followed by group 1 (diabetic non obese) and group 3 (controls) showed the best figures. Also BMI was much higher among group 2 (diabetic obese) compared to both groups 1 and 3. *conclusion:Dyslipidemia increases the risk of CVD in type-2 diabetic patients. Yifen Liu, Prasanna Rao-Balakrishna, Rayaz et al.2016). Adiposity, defined by higher cardiometabolic index (CMI), lipid accumulation product (LAP), and body adiposity index (BAI), has conferred increased metabolic risk. (Haoyu Wang , Yintao Chen et al 2018). The ratio of triglycerides to HDL-C (TG/HDL-C ratio) has been proposed to be a good discriminator for cardiovascular risk , also (TG/HDL-C) has been shown to be associated with insulin resistance (McLaughlin et al., PDF created with pdfFactory Pro trial version www.pdffactory.com SOHAG MEDICAL JOURNAL The "cardiometabolic index" as a new marker determined by adiposity Vol. 22 No.